A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248

NCT00531544 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
350
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

King Faisal Specialist Hospital & Research Center